MGAH22

· MacroGenics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MGAH22, covering 2025-02-26 to 2025-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of MGAH22 in HER2-positive Carcinomas [Phase 1]